The Directors of the Human Immunology and Immunotherapy Initiative are leaders in the fields of tolerance and autoimmunity, allergy and clinical immunology, and cancer biology.
Faculty in the Human Immunology and Immunotherapy Initiative have expertise in a wide range of areas relevant to basic and/or translational research in the field of immunology.
The HI3 has welcomed the participation of all immunology and immunotherapy-related basic and/or clinical and translational investigators at all levels of training and expertise on the greater Anschutz Medical Campus as members.
The mission of the Human Immunology and Immunotherapy Initiative is to establish an all-inclusive premier facility on the CU Anschutz medical campus focused on the comprehensive development and delivery of human immune system-targeted therapies.